Northern Africa - Press Releases

PITTSBURGH, May 6, 2025 /PRNewswire/ -- "I wanted to create a unique and mischievous little skeleton character/toy that is a friend to children but also likes to play harmless and playful Halloween tricks," said an inventor, from Woodend, QLD, Australia, "so I invented the Skelfie. My design allows parents and children to have fun all month long leading up to Halloween, discovering and delighting in Skelfie's Halloween antics, tricks and treats throughout the home or neighborhood."

Rooted in Jewish values, new abortion fund anchored by compassion and inclusion marks a year of impact in the fight for reproductive freedom

PITTSBURGH, May 6, 2025 /PRNewswire/ -- "I wanted to create an improved GPS tracking system specifically for school bus trips," said an inventor, fromMertzon, Texas, "so I invented the BUZ CONNEX. My design ensures only the parents and guardians of the students can track the bus location to know where their children are and when they'll return for timely pickup at the school."

Nearly 45,000 Florida Children and Thousands of Jobs at Risk if Program is Eliminated

New approach could update treatment and monitoring protocols

ATLANTA, 6 de mayo de 2025 /PRNewswire-HISPANIC PR WIRE/--The Home Depot, la tienda minorista ms grande del mundo de artculos para el hogar, anunci hoy que celebrar su conferencia telefnica sobre los resultados del primer trimestre el martes 20 de mayo a las 9:00 a. m., hora del este.

PLANO, Texas, 6 de mayo de 2025 /PRNewswire-HISPANIC PR WIRE/ -- Las cosas estn a punto de ponerse muy buenas, muy rpido.

ST. CHARLES, Mo., May 6, 2025 /PRNewswire/ -- May marks Mental Health Awareness Month-a time to recognize the emotional challenges faced by millions, including our nation's veterans. In honor of this important month, Recon Supply, a Service-Disabled Veteran-Owned Small Business (SDVOSB), and Harvard MedTech, a leader in virtual reality-based trauma recovery, proudly celebrate their partnership in bringing Vx Therapy directly into the homes of veterans across the country.

SEBASTOPOL, Calif., y VENICE, Calif., 6 de mayo de 2025 /PRNewswire-HISPANIC PR WIRE/ -- Guayak Yerba Mate, pionero enbebidas de yerba mate regenerativa en Amrica del Norte, cambia su marca a Yerba Madreun nuevo nombre que refleja un mayor compromiso con las personas y el planeta, y las races ancestrales de la yerba mate.

ALEXANDRIA, Va., May 6, 2025 /PRNewswire/ -- National PTA is pleased to announce thatHowie Berman, MA, CAE has been named the association's new executive director. Berman brings more than two decades of professional experience within the nonprofit association space, including more than a dozen years with education-focused organizations. He most recently served as interim executive director for the National Federation of Modern Language Teachers Associations (NFMLTA), a nonprofit organization that promotes research and improvement in the teaching and learning ofmodernworldlanguages. Prior to this position, Berman spent five years as executive director of ACTFL (formerly the American Council on the Teaching of Foreign Languages). He has also served as chief operating officer of ACTFL and director of information technology and membership services at the American Society for Cell Biology.

ADDISON, Texas, May 6, 2025 /PRNewswire/ -- LineLeader by ChildcareCRM ("LineLeader"), the leading provider of unified SaaS software and digital payment solutions for the early childhood education (ECE) market,announced the launch of the Custom Report Builder in their management system, LineLeader Manage, bringing unparalleled flexibility and insight to reporting for ECE organizations.

ATLANTA, May 6, 2025 /PRNewswire/ -- StaffHealth (www.staffhealth.com), a trusted leader in healthcare staffing solutions nationwide, proudly announces its decision to join the Accushield Verified Alliance- a move that underscores the company's ongoing commitment to transparency, resident safety, and exceptional service in senior living communities.

WASHINGTON, May 6, 2025 /PRNewswire/ -- On Saturday, May 17, 2025, National Park Trust will commemorate the 15th anniversary of Kids to Parks Day. This grassroots national day of park appreciation encourages kids and families to discover, explore, and celebrate their local, state, and national parks.

Middle school teams honored for innovative solutions to protect oceans, with Grand Prize winnersearning trip to Los Angeles and hands-on STEAM experiences

The $100,000 Sands Cares contribution underwrites organizational capacity building to enable services for unemployed and underemployed women.

NASHVILLE, Tenn., May 6, 2025 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) ("Brookdale" or the "Company") announced results for the quarter ended March 31, 2025.

Heroes Vodka launches nationwide search for a hero who will be featured on a limited-edition bottle with proceedsgifted to the charity of their choice

ALEXANDRIA, Va., May 6, 2025 /PRNewswire/ -- Teachers go above and beyond every day to support children's success in and out of the classroom. To thank, honor and elevate how"Teachers Light the Way to Brighter Futures," PTA will markTeacher Appreciation WeekMay 5-9.

YUTIQ addresses a significant unmet need in the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. The uveitis treatment market is projected to grow steadily, driven by rising incidence and improved diagnosis, positioning YUTIQ for strong market adoption.

SAN DIEGO, May 6, 2025 /PRNewswire/ --Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of West Pharmaceutical Services, Inc. (NYSE: WST) common stock between February 16, 2023 and February 12, 2025, inclusive (the "Class Period"), have until July 7, 2025 to seek appointment as lead plaintiff of the West Pharmaceutical class action lawsuit. Captioned New England Teamsters Pension Fund v. West Pharmaceutical Services, Inc., No. 25-cv-02285 (E.D. Pa.), the West Pharmaceutical class action lawsuit charges West Pharmaceutical and certain of West Pharmaceutical's current and former top executives with violations of the Securities Exchange Act of 1934.

Rsum de l'actualit

LEXINGTON, Mass., May 6, 2025 /PRNewswire/ --Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Board of Directors of Curis approved the grant of inducement stock options to its newly appointed Chief Medical Officer, Dr. Ahmed Hamdy to purchase 200,000 shares of Curis common stock, with a grant date of May 1, 2025 (the "Inducement Grant").

TAIPEI, May 6, 2025 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Apotex Inc. ("Apotex"), for exclusive rights in Mexico for the commercialization of clobetasol propionate ophthalmic suspension, 0.05% (APP13007), a patented innovative medicine for the treatment of inflammation and pain following ocular surgery. Clobetasol propionate ophthalmic suspension, 0.05% (APP13007) was approved by the U.S. Food and Drug Administration (FDA) in 2024. APP13007's active ingredient is the superpotent corticosteroid, clobetasol propionate, and is derived from Formosa Pharma's proprietary APNT nanoparticle formulation platform. The novel formulation enables a convenient and straightforward dosing regimen, while providing rapid and sustained relief of inflammation and pain, which in Phase 3 trials proved statistically and clinically superior to its matching placebo (p<0.001).

WASHINGTON, May 6, 2025 /PRNewswire/ -- The Independence Fund, a national non-profit organization dedicated to serving the needs of catastrophically wounded Veterans and their families, was honored to join six of our nation's Veterans at today's Senate Committee on Veterans' Affairs hearing, "Veterans at the Forefront: Secretary Collins on the Future at VA."

SAN DIEGO, May 6, 2025 /PRNewswire/ -- Adcentrx Therapeutics("Adcentrx"), a clinical-stage biotechnology company redefining Antibody-Drug Conjugate (ADC) therapies for cancer treatment and other life-threatening diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program, ADRX-0706, for the treatment of patients with locally advanced or metastatic squamous cell cervical cancer.